{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:34:36Z","timestamp":1787891676591,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bcp.2020.114136","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T11:17:21Z","timestamp":1593775041000},"page":"114136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Oridonin is an antidepressant molecule working through the PPAR-\u03b3\/AMPA receptor signaling pathway"],"prefix":"10.1016","volume":"180","author":[{"given":"Ping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.bcp.2020.114136_b0005","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.bcp.2020.114136_b0010","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.bcp.2020.114136_b0015","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114136_b0020","series-title":"Active Phytochemicals from Chinese Herbal Medicines: Anti-Cancer Activities and Mechanisms","author":"Ho","year":"2015"},{"issue":"10","key":"10.1016\/j.bcp.2020.114136_b0025","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1461145710000970","article-title":"Is there a role for the nuclear receptor PPAR\u03b3 in neuropsychiatric diseases?","volume":"13","author":"Garc\u00eda-Bueno","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114136_b0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1523\/JNEUROSCI.3280-15.2016","article-title":"Activation of PPAR\u03b3 ameliorates spatial cognitive deficits through restoring expression of AMPA receptors in seipin knock-out mice","volume":"36","author":"Zhou","year":"2016","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2020.114136_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn2055","article-title":"Regulatory mechanisms of AMPA receptors in synaptic plasticity","volume":"8","author":"Derkach","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2020.114136_b0040","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1523\/JNEUROSCI.16-06-01982.1996","article-title":"Evidence for multiple AMPA receptor complexes in hippocampal CA1\/CA2 neurons","volume":"16","author":"Wenthold","year":"1996","journal-title":"J. Neurosci."},{"issue":"6789","key":"10.1016\/j.bcp.2020.114136_b0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/35016089","article-title":"Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity","volume":"405","author":"Lee","year":"2000","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2020.114136_b0050","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1523\/JNEUROSCI.19-12-04972.1999","article-title":"Impairments in high-frequency transmission, synaptic vesicle docking, and synaptic protein distribution in the hippocampus of BDNF knockout mice","volume":"19","author":"Pozzo-Miller","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114136_b0055","article-title":"Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient","volume":"91","author":"Bermejo","year":"2014","journal-title":"JoVE"},{"issue":"9","key":"10.1016\/j.bcp.2020.114136_b0060","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1017\/S1461145711001544","article-title":"Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood","volume":"15","author":"Labonte","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114136_b0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1074\/jbc.M509677200","article-title":"Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation","volume":"281","author":"Oh","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2020.114136_b0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.pnpbp.2007.05.002","article-title":"Effect of various classes of antidepressants in behavioral paradigms of despair","volume":"31","author":"Kulkarni","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2020.114136_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114136_b0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/sj.mp.4001457","article-title":"In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice","volume":"9","author":"Cryan","year":"2004","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2020.114136_b0085","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2020.114136_b0090","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-3223(97)00426-5","article-title":"Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone\u2014a multiple-dose study","volume":"44","author":"McCance-Katz","year":"1998","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2020.114136_b0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2020.114136_b0100","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/molecules23020474","article-title":"Therapeutic potential of oridonin and its analogs: from anticancer and antiinflammation to neuroprotection","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.bcp.2020.114136_b0105","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1055\/s-0033-1350797","article-title":"In vitro permeability study of CNS-active diterpenes from Sideritis spp. using cellular models of blood-brain barrier","volume":"79","author":"Gonz\u00e1lez-Burgos","year":"2013","journal-title":"Planta Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114136_b0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12015-008-9024-2","article-title":"Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation","volume":"4","author":"Cimini","year":"2008","journal-title":"Stem Cell Rev."},{"issue":"21","key":"10.1016\/j.bcp.2020.114136_b0115","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1523\/JNEUROSCI.1004-07.2007","article-title":"NP031112, a thiadiazolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders","volume":"27","author":"Luna-Medina","year":"2007","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2020.114136_b0120","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1167\/iovs.02-1060","article-title":"Role of PPAR-\u03b3 ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells","volume":"44","author":"Aoun","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2020.114136_b0125","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0092-8674(01)00406-8","article-title":"AMPA receptor trafficking and the control of synaptic transmission","volume":"105","author":"Sheng","year":"2001","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bcp.2020.114136_b0130","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1074\/jbc.M116.774554","article-title":"GluA1 subunit ubiquitination mediates amyloid-\u03b2-induced loss of surface \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors","volume":"292","author":"Guntupalli","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2020.114136_b0135","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuroscience.2008.03.007","article-title":"Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex","volume":"153","author":"Tokarski","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2020.114136_b0140","unstructured":"C. Rosenmund, C. Stevens, Channel conductance of a AMPA-type glutamate channel is determined by agonist concentration, Biophys. J. 70(2) (1996) TUAM1-TUAM1."},{"issue":"5547","key":"10.1016\/j.bcp.2020.114136_b0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/260101a0","article-title":"Possible role for cyclic nucleotides and phosphorylated membrane proteins in postsynaptic actions of neurotransmitters","volume":"260","author":"Greengard","year":"1976","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2020.114136_b0150","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1523\/JNEUROSCI.20-01-00089.2000","article-title":"Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase","volume":"20","author":"Banke","year":"2000","journal-title":"J. Neurosci."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:14:19Z","timestamp":1757769259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":30,"alternative-id":["S0006295220303725"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114136","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oridonin is an antidepressant molecule working through the PPAR-\u03b3\/AMPA receptor signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114136","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114136"}}